Open AccessA Comparison of Thrombosis and Hemorrhage Rates in Patients With Severe Respiratory Failure Due to Coronavirus Disease 2019 and Influenza Requiring Extracorporeal Membrane Oxygenation
Author(s) -
Andrew J. Doyle,
Beverley J. Hunt,
Barnaby Sanderson,
Joe Zhang,
Sze Mun Mak,
Giulia Benedetti,
Karen Breen,
Luigi Camporota,
Nicholas Barrett,
Andrew Retter
Publication year - 2021
Publication title -
critical care medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.002
H-Index - 271
eISSN - 1530-0293
pISSN - 0090-3493
DOI - 10.1097/ccm.0000000000004971
Subject(s) - medicine , extracorporeal membrane oxygenation , pneumonia , respiratory failure , thrombosis , population , coronavirus , retrospective cohort study , surgery , anesthesia , disease , covid-19 , infectious disease (medical specialty) , environmental health
Extracorporeal membrane oxygenation is a lifesaving therapy for patients with severe acute respiratory distress syndrome refractory to conventional mechanical ventilation. It is frequently complicated by both thrombosis and hemorrhage. A markedly prothrombotic state associated with high rates of venous thromboembolism has been described in patients with severe acute respiratory syndrome coronavirus 2 (coronavirus disease 2019) infection. These rates have currently not been described during extracorporeal membrane oxygenation in comparison to other viral pneumonias.